Soluble fibronectin interaction with cell surface and extracellular matrix is mediated by carbohydrate-to-carbohydrate interaction.
Cell adhesion and spreading on solid phase fibronectin (FN), coated on plate or presented in extracellular matrix, are mediated by integrin receptors alpha5beta1, alpha4beta1, etc., although binding of "soluble-form FN" to cell surface varies extensively depending on glycosylation status of FN per se. Deposition or incorporation at the cell surface or pericellular matrix of soluble-form FN from body fluids or synthesized de novo takes place through a yet-unknown (perhaps integrin-independent) mechanism. Here we present evidence that the mechanism involves carbohydrate-to-carbohydrate interaction. Binding or incorporation of soluble-form placental or hepatoma FN to cell surface or pericellular matrix is highly dependent on the specific glycosylation status of FN per se and combination with glycosylation status of the cell surface, and is greatly promoted by a certain type of coexisting (shedded) glycosphingolipid. A few lines of study indicate that the process is mediated by interaction of FN carbohydrate with cell surface carbohydrate. The great enhancement of the binding process by glycosphingolipid is based on dual interaction of glycosphingolipid carbohydrate with FN carbohydrate and with cell surface carbohydrate. Here we present an example of promotion of binding of soluble-form FN from placenta or from hepatoma cells, having a specific carbohydrate epitope termed "disialyl-I," to K562 or VA13 cell surface in the presence of glycosphingolipid Gg3, which interacts specifically with disialyl-I.
Zheng
M
M
Department of Physiology and Cell Biology, Albany Medical College, 47 New Scotland Avenue, Albany, New York 12208, USA.
Hakomori
S i
Si
D000818:Animals; D050260:Carbohydrate Metabolism; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism*; D005353:Fibronectins / Q000737:chemistry / Q000378:metabolism*; D005732:Gangliosides; D006028:Glycosphingolipids / Q000502:physiology; D006801:Humans; D016023:Integrins / Q000502:physiology; D020014:K562 Cells; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000378:metabolism; D010920:Placenta / Q000737:chemistry; D011134:Polysaccharides / Q000378:metabolism; D011485:Protein Binding; D012995:Solubility; D014407:Tumor Cells, Cultured
D005353:Fibronectins; D005732:Gangliosides; D006028:Glycosphingolipids; D016023:Integrins; D008562:Membrane Glycoproteins; D011134:Polysaccharides; C038244:ganglio-N-triaosylceramide